Shamburg News · 8-K filed Nov 3, 2026, 5:00 PM EST
NeOnc Technologies to Present NEO100 and NEO212 Data at Society for Neuro-Oncology Meeting
NTHI · NEONC TECHNOLOGIES HOLDINGS, INC.
- Other event
- Reg FD disclosure
- Materiality: low
On November 2, 2026, NeOnc Technologies Holdings, Inc. issued a press release, furnished as Exhibit 99.1 under Regulation FD, announcing that data from its intranasal NEO100 and oral NEO212 programs will be presented in two posters. The posters are scheduled for November 13, 2026, at the 31st Annual Meeting and Education Day of the Society for Neuro-Oncology in Philadelphia, held November 12 to 15, 2026. The filing reports no financial results, dividends, splits, or officer changes.
Source: SEC EDGAR, Form 8-K, Items 7.01, 9.01, accession 0001829126-26-011937.
Written from the filing by Shamburg Markets. Figures are as reported by the company.